News Archives - Casma Therapeutics

Our team
Investors
News & media
Contact us

The science: autophagy
Platform & pipeline
About us
Careers & culture

Our team
Investors
News & media
Contact us

news page

About Casma

Casma Therapeutics is developing novel cellular degradation approaches based on the autophagy pathway to initiate new target areas for drug discovery and development that will profoundly impact the lives of patients. Autophagy is a conserved cellular process that contributes to overall cellular homeostasis. The autophagy machinery focuses on larger and more complex disease targets, such as organelles, protein aggregates, and large signaling complexes, and directs these targets to the lysosome for elimination. Through selective degradation of disease targets, Casma expects to arrest or reverse the progression of disease in multiple oncology, inflammation, neurodegeneration, and metabolic disorders.

Contact us

Casma Therapeutics, Inc
400 Technology Square, Suite 201
Cambridge, MA 02139

(857) 777-4990
contact@casmatx.com

Quick links

Careers & culture
Investors
News & media
Our team
The science: autophagy

Fierce 15 list award in 2019

Privacy Policy
Terms of use